Quality of facilities.
Identify key differences and commonalities between the UK and US care management systems and structures within which they operate.
Cite lessons from integrating care management into practice at the grassroots level to support the GP-patient relationship and how those lessons might be translated for the US.
List the key differences between the healthcare systems in Japan and the US.
Discuss recent Japanese government regulation of population screening and management programs.
Describe cases of metabolic syndrome screening and management programs in Japan.
Assess the overall progress of creating a national population management program for chronic disease prevention in Japan.
Demonstrate how video games for health are being used for wellness and condition management by leading health organizations.
Describe the evidence and experience supporting the effectiveness of video games for health that has been funded by Robert Wood Johnson Foundation, HopeLab and others.
Explore how the Re-Mission video game for cancer works to improve treatment adherence and self-efficacy in teenagers with cancer.
Explain the importance of early diagnosis and treatment of psoriatic disease.
Discuss the scientific evidence from various disease states that demonstrates the efficacy and safety of different therapeutic agents for psoriasis and psoriatic arthritis.
Apply emerging knowledge of comorbidites in psoriatic disease to provide patients with individualized treatment strategies.
Define the role of dermatology healthcare professionals in improving the psoriatic patient’s overall quality of life.
Measure outcomes validly and transparently.
Draw and interpret historical comparisons and comparison across health plans.
Develop a valid ROI based on adverse event avoidance.
Assess the effectiveness of active physician engagement in EBM opportunity management against traditional outreach metrics.
Assess the effectiveness of Pay-for-Outcomes incentives as an aid to achieving chronic disease risk factor reductions.
Evaluate the response of the physician community to physician outreach and engagement on these clinical opportunities.
List major provisions and discuss the intent of HITECH legislation.
Explore role of health IT in care coordination.
Discover opportunities in HITECH legislation for members of the DMAA community.
Recognize the impact of optimal lifestyle adherence on disease prevention.
Discuss the importance of optimal lifestyle adherence as a metric for population health management.
Identify gaps in care using administrative datasets.
Explain how different channels for communication affect the impact of information delivered to physicians.
Describe how analytics can assist health plans to improve the care delivered by individual physicians.
Discuss the identification process in disease management program.
Develop knowledge on different identification regimes – prospective, annual requalification, graduation.
List various evaluation techniques, particularly those related to measuring intervention impacts.
Discuss measuring/developing program savings and ‘return on investment’ (ROI) measures.
Identify the core components of the Geisinger ProvenHealth Navigator SM (PHN) model.
Explain the Patient Activation Measure (PAM) and how it impacts health decisions and goals.
Describe the results of a randomized controlled study comparing PAM changes between intervention groups.
Discuss practical use of the PAM, training requirements for adopting PAM measurement including how the measure affects client and clinician interactions.
Explain the development of, and concepts encompassed in the Patient Activation Measure (PAM™), and how different health behaviors relate to levels of activation.
Explain what clinical decision support is, what you need to do it, and how it clinical alerting works today. Attendees will be able to describe the functioning of a system for alerting physicians and patients about potential gaps in care.
Discuss an actual case of delivering alerts through a trusted intermediary and electronic medical record (EMR). Attendees will be able to describe two ways in which the effectiveness of a clinical alerting system can be enhanced.
Discuss improvements in quality and cost with clinical decision support and clinical alerting, with trusted EMR-enabled intermediaries. Attendees will be able to name two outcome measures for assessing the impact of a clinical alerting system.
Discuss the future of clinical decision support in the patient-centered medical home.
Discuss the guidelines for evaluation mature programs.
Provide examples on ways to effectively evaluate wellness programs.
Outline operational process measures.
Define the role of medication adherence measures.
Discuss the role of small, achievable weight loss goals in reducing risk for some chronic diseases and identify key outcome measures appropriate for short-term analysis.
Describe the quantitative and qualitative benefits of two approaches to worksite health promotion programs.
Analyze the initial results of both projects and identify potential for modifications and continuation.
Discuss the preventive need and scope of the problem in a state with a high proportion of childhood obesity.
Identify eligible members and select appropriate interventions to modify behavior.
Cite strategies for collaborating with internal and external stakeholders to create a paradigm shift in the prevention and treatment of childhood obesity.
Apply strategies for increasing member accessibility to programs which emphasize healthy lifestyles.
Explain new additions to the DMAA Obesity Toolkit, including case studies and a prototype algorithm.
Discuss the process of implementing an obesity benefit.
Apply knowledge of lessons learned to implementing an obesity benefit within their own organization.
Describe the issue of obesity and how new technologies can be used to deliver health interventions.
Explain the design of the virtual coaching platform used in this study.
Describe the design of this clinical research trial.
Discuss the positive impact of an automated virtual coaching system on patient activity levels.
Describe the collaborative policy development process used to advance the expansion of telehealth in California.
Identify the policy recommendations set forth by the collaborative.
Discuss the specific actions that will optimize the use of telemedicine.
Cite current challenges governors are facing and how disease management may address such challenges.
Explain the mechanisms states have used to pursue disease management initiatives.
Describe the successes and challenges states have seen in implementing disease management initiatives.
Discuss what implications federal and state policies might have on the future of disease management initiatives.
Recognize the cost burden of traditional long-term anticoagulation monitoring and clinical and financial value of patient self-testing.
Describe the INR patient self-testing program design and how the physician program supports the physician-patient relationship.
Identify key program outcomes, including patient self-testing, compliance rate and adverse event reports.
Define comparative effectiveness implications for key stakeholders: Consumers, Providers, and payers.
Explain the implications of comparative effectiveness for US health policy and aspects of reform.
Discuss the benefits of targeting members who have a high receptivity to coaching, with high financial risk and clinical conditions that have a high degree of sensitivity to coaching activities.
Describe how principles of unwarranted variation and evidence-based healthcare can be used to enhance a deeper, broader and more intensive care management program
Develop a new measurement methodology to evaluate program effectiveness that takes into account members with more than chronic conditions.
Discuss how collaborative care and HIT address delivery system challenges that involve complex and largely uncoordinated relationships between patients, physicians and payers.
Describe how Henry Ford Health System and Park Nicollet Health Services use collaborative care and HIT as part of the medical home to achieve industry leading, breakthrough engagement levels and clinical and financial performance improvement.
Explain how to maximize program engagement through data and technology.
Explain how offering financial incentives through a partnership with a provider network may help integrate physicians into population health disease management programs.
Discuss research that demonstrates that when coaches and physicians communicate, better outcomes are achieved.
Discuss how to leverage health benefit design strategy to empower employees to take more personal responsibility for better health.
Discuss how to create a culture of health that supports employee behavior change.
Explain the components necessary to develop and implement a health management program with strong ROI.
Describe the three components of the program including the role of providers and clinical staff in each component.
List four critical activities that must take place in order to reduce admissions.
List four challenges that you can expect in implementing a similar program.
Discuss an innovative and effective approach to measuring cost savings in a population health management program.
Assess the impact of population health programs overall and in particular segments of a broad population.
Discuss the merits of broadening this approach to other programs.
Describe factors that place a pregnancy at high-risk for adverse outcomes.
List the components of a Medical Home program during pregnancy.
Discuss the impact of the program in both Commercial and Medicaid populations.
Discuss how Together for Quality enhances Patient 1st, the Alabama Medicaid medical home model.
Discuss the strategies used to educate and encourage provider adoption of electronic health records.
Identify measures used that are population sensitive and how these relate to nationally accepted standards.
Identify the components and steps necessary for successful health information exchange implementation.
Explore the opportunities and challenges of transitioning from a cash-based to benefit-based incentive program.
Discuss critical success factors influencing employee participation beyond cash rewards.
Highlight program outcomes that support evidence/data-based decisions for focusing program participation goals on what will bring the greatest value.
Identify the impact of insomnia and depression on medical outcomes, healthcare costs, and workplace productivity.
Discuss problems in the treatment of depression and insomnia.
Define the role of digital coaching (online CBT) in the treatment of depression and insomnia.
Discuss the strategy and preliminary findings regarding the use of digital coaching to enhance the treatment of depression and insomnia.
Review the outcome data resulting from a randomized controlled trial of an automated coaching program for insomnia.
Explain the importance of managing readmission and the challenges to measuring readmission rates as outcomes for care.
Present some methodological considerations for the calculation of readmission rates using administrative claims data.
Explain how to apply the appropriate readmission method to measure outcomes for different programs based on specific program designs and objectives.
Do you believe this activity was appropriate for the scope of your professional activities?
My professional competence would be improved if I had training on:
My professional performance would be improved if I had training on:
My patient outcomes would be improved if I had training on:
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How can this training be improved to better impact competence, performance and/or patient outcomes?
Additional comments:
